Drawing for SUSTINE

USPTO serial 77084278

SUSTINE

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
EDWARDS, ALICIA COLLINS
Law office
PETITIONS OFFICE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SUSTINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nadine P. Flynn

NADINE P. FLYNN BRISTOL-MYERS SQUIBB COMPANY345 PARK AVENUETRADEMARK DEPARTMENTNEW YORK, NY 10154

Goods and services

ClassDescriptionStatusFirst use
005Hydrogel for the treatment of woundsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 12, 2007MAB5ABANDONMENT NOTICE MAILED - AFTER PUBLICATION—
Oct 12, 2007ABN5ABANDONMENT - AFTER PUBLICATION—
Sep 20, 2007EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Sep 20, 2007ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Aug 21, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 1, 2007NPUBNOTICE OF PUBLICATION—
May 12, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 11, 2007ALIEASSIGNED TO LIE—
Apr 25, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 25, 2007DOCKASSIGNED TO EXAMINER—
Jan 22, 2007NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance